HK Pharma stocks shined. Wuxi Apptec and Alphamab surged 11%, Wuxi Bio soared 8%, Wuxi XDC up 7%, Tigermed up 5%.
Wuxi Apptec reported a net profit of 2.917 billion yuan in the fourth quarter of last year, marking a 27.21% quarter-on-quarter increase.